Atlas Trials

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Clinical trial NCT04405401 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04405401
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer Metastatic
Start date
2021-01-05
Primary completion
2026-12-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.